IFNA17 and COVID-19: Our results thus far demonstrating lower IFNα plasma levels in severe disease, yet similar kinetics across COVID-19 disease states, suggests that induction of IFN-I in the absence of autoantibodies is critical to understand defective anti-viral immunity in severe COVID-19.